These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 117638)
21. Antimicrobial activity of human peritoneal fluid. Bercovici B; Michel J; Miller J; Sacks TG Surg Gynecol Obstet; 1975 Dec; 141(6):885-7. PubMed ID: 242084 [TBL] [Abstract][Full Text] [Related]
22. Vitamin B12 requirement for the growth of Trichomonas vaginalis in vitro. Hollander DH; Leggett NC J Parasitol; 1985 Oct; 71(5):683-4. PubMed ID: 3877156 [No Abstract] [Full Text] [Related]
23. The effect of Trichomonas vaginalis and the role of pH on cell culture monolayer viability. Garber GE; Bowie WR Clin Invest Med; 1990 Apr; 13(2):71-6. PubMed ID: 1693888 [TBL] [Abstract][Full Text] [Related]
24. The interaction of Lactobacillus acidophilus and Trichomonas vaginalis in vitro. McGrory T; Meysick K; Lemchuk-Favel LT; Garber GE J Parasitol; 1994 Feb; 80(1):50-4. PubMed ID: 8308658 [TBL] [Abstract][Full Text] [Related]
25. [Morphology and biological activity of Trichomonas vaginalis grown on various nutrient media]. Vasil'ev MM; Bednova VN; Bragina EE; Dmitriev GA Vestn Dermatol Venerol; 1988; (8):23-6. PubMed ID: 3264099 [No Abstract] [Full Text] [Related]
26. Comparable growth of a Trichomonas vaginalis strain in PEHPS and TYI-S-33 media. Castro-Garza J; Anaya-Velázquez F; Said-Fernández S; González-Garza MT Arch Med Res; 1996; 27(4):567-9. PubMed ID: 8987196 [TBL] [Abstract][Full Text] [Related]
27. Effect of oxygen and carbon dioxide on the growth of Trichomonas vaginalis and Tritrichomonas foetus. Mack SR; Müller M J Parasitol; 1978 Oct; 64(5):927-9. PubMed ID: 309937 [No Abstract] [Full Text] [Related]
28. [Relation between Chlamydia trachomatis and Trichomonas vaginalis in vitro]. Shcherbakova NI; Bragina EE; Iashkova GN; Voskresenskaia GA Vestn Dermatol Venerol; 1983 Mar; (3):17-9. PubMed ID: 6344497 [No Abstract] [Full Text] [Related]
29. [Stimulation of antibodies to pathogenic microorganisms in animals by immunizing them with saprophytes]. Trutnev BD; Podlenykh TP; Klepova NI; Trepalina IuD Zh Mikrobiol Epidemiol Immunobiol; 1969 Jul; 46(7):98-101. PubMed ID: 4986751 [No Abstract] [Full Text] [Related]
30. [Cytotoxic activity of Trichomonas vaginalis supernatants toward cellular monolayers]. Martinotti MG; Merlino C; Savoia D G Batteriol Virol Immunol; 1986; 79(7-12):279-87. PubMed ID: 3502600 [TBL] [Abstract][Full Text] [Related]
31. [A dried nutrient medium made from the fermented hydrolysates of a microorganism biomass for isolating Trichomonas vaginalis]. Bednova VN; Vakhnina TE; Golovkina GP; Timonina LF; Spevak MV Vestn Dermatol Venerol; 1988; (10):13-6. PubMed ID: 3265559 [No Abstract] [Full Text] [Related]
32. Lung surfactant protein A (SP-A) enhances serum-independent phagocytosis of bacteria by alveolar macrophages. Manz-Keinke H; Plattner H; Schlepper-Schäfer J Eur J Cell Biol; 1992 Feb; 57(1):95-100. PubMed ID: 1639094 [TBL] [Abstract][Full Text] [Related]
33. Use of solid medium techniques to evaluate factors affecting the ability of Trichomonas vaginalis to survive freezing. Ivey MH J Parasitol; 1975 Dec; 61(6):1101-3. PubMed ID: 1081590 [No Abstract] [Full Text] [Related]
34. [Opsonizing activity of the serum of gnotobiotic guinea pigs contaminated with individual representatives of intestinal microflora]. Andreev VN; Podoprigora GI Biull Eksp Biol Med; 1977 Feb; 83(2):196-8. PubMed ID: 403978 [TBL] [Abstract][Full Text] [Related]
35. [Vagicult set for detection of Trichomonas vaginalis and yeasts in vaginal smears]. Zaremba M; Rutkowska T; Małyszko E; Borowski J Pol Tyg Lek; 1978 Dec; 33(49):1901-4. PubMed ID: 310116 [No Abstract] [Full Text] [Related]
36. [Trichomonas vaginalis, a reservoir for retention of the gonococcus. The treatment of a mixed gonorrhea-trichomonas infection]. Ovchinnikov NM; Delektorskiĭ VV; Turanova EN; Iashkova GN Vestn Dermatol Venerol; 1978 Apr; (4):16-21. PubMed ID: 418592 [No Abstract] [Full Text] [Related]
37. Phagocytosis of Escherichia coli and Staphylococcus aureus by neutrophils of human immunodeficiency virus-infected patients. Schaumann R; Krosing J; Shah PM Eur J Med Res; 1998 Dec; 3(12):546-8. PubMed ID: 9889173 [TBL] [Abstract][Full Text] [Related]
38. Kinetics of phagocytosis of Staphylococcus aureus and Escherichia coli by human granulocytes. Leijh PC; van den Barselaar MT; van Zwet TL; Dubbeldeman-Rempt I; van Furth R Immunology; 1979 Jun; 37(2):453-65. PubMed ID: 381182 [TBL] [Abstract][Full Text] [Related]
39. A role for IgM in the in vitro opsonisation of Staphylococcus aureus and Escherichia coli by bovine polymorphonuclear leucocytes. Williams MR; Hill AW Res Vet Sci; 1982 Jul; 33(1):47-53. PubMed ID: 6753075 [TBL] [Abstract][Full Text] [Related]
40. Variation among cows in the ability of their blood polymorphonuclear leucocytes to kill Escherichia coli and Staphylococcus aureus. Williams MR; Bunch KJ Res Vet Sci; 1981 May; 30(3):298-302. PubMed ID: 7020019 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]